Cancer diagnostics company Pacific Edge is looking to raise $80 million, just weeks after denying it was looking to raise A$70m following an announcement to the Australian Stock Exchange.
The NZX-listed company has gone into a trading halt this morning as it announced the capital raise,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
